651 A phase 1, multicenter, open-label, dose-escalation, safety, pharmacodynamic, pharmacokinetic study of Q702 with a cohort expansion at the RP2D in patients with advanced solid tumors
Mahalingam, Devalingam, Alistar, Angela, Mita, Alain, Kim, Jeongjun, Ahn, Hyunji, Choi, Jinho, Ryu, Seung-Hee, Ahn, Jiye, Choi, Bae Jung, Kang, Hwankyu, Yang, Yeong-In, Lee, Seung-Joo, Jeon, Borami, Proniuk, Stefan, Nam, Kiyean, El-Khoueiry, Anthony
Published in Journal for immunotherapy of cancer (01.11.2023)
Published in Journal for immunotherapy of cancer (01.11.2023)
Get full text
Journal Article
645 A phase 1B/2, open-label study of Q702 in combination with intravenous pembrolizumab in patients with selected advanced solid tumors
Kim, Seung-Tae, Chon, Hong Jae, Oh, Do-Youn, Grewal, Jaspreet, Rha, Sun Young, El-Khoueiry, Anthony, Ryoo, Baek-Yeol, Kim, Jeongjun, Ahn, Hyunji, Ryu, Seung-Hee, Choi, Jinho, Choi, Bae Jung, Ahn, Jiye, Kang, Hwankyu, Yang, Yeong-In, Lee, Seung-Joo, Jeon, Borami, Proniuk, Stefan, Nam, Kiyean
Published in Journal for immunotherapy of cancer (01.11.2023)
Published in Journal for immunotherapy of cancer (01.11.2023)
Get full text
Journal Article
(1S,3S)-N1-피라졸로[1,5-A]피리미딘-7-일)시클로펜탄-1,3-디아민의다형체 및 염 형태
YEH GEOFFREY, PRONIUK STEFAN, PAUL BERNHARD, ZHANG XINNAN, STEENDAM RENE, PHIASIVONGSA PASIT, FREEMAN DAVID
Year of Publication 15.07.2024
Get full text
Year of Publication 15.07.2024
Patent
Exploring the in vitro potential of celecoxib derivative AR-12 as an effective antiviral compound against four dengue virus serotypes
Hassandarvish, Pouya, Oo, Adrian, Jokar, Amin, Zukiwski, Alexander, Proniuk, Stefan, Abu Bakar, Sazaly, Zandi, Keivan
Published in Journal of antimicrobial chemotherapy (01.09.2017)
Published in Journal of antimicrobial chemotherapy (01.09.2017)
Get full text
Journal Article
ACTR-40. PHASE 2 SAFETY AND EFFICACY OF AR-67 (7-T-BUTYLDIMETHYLSILTYL-10-HYDROXYCAMPTOTHECIN) IN PATIENTS WITH RECURRENT GLIOBLASTOMA MULTIFORME (GBM) OR GLIOSARCOMA
Kumthekar, Priya, Raizer, Jeffrey, Cavaliere, Robert, Devoe, Craig, Jensen, Randy, Stieber, Volker, Runk, Tina, Grewal, Jai, Brownell, Elise, Zukiwski, Alex, Proniuk, Stefan, Arnold, Susanne, Vredenburgh, James
Published in Neuro-oncology (Charlottesville, Va.) (11.11.2019)
Published in Neuro-oncology (Charlottesville, Va.) (11.11.2019)
Get full text
Journal Article
Abstract 4636: Pharmacokinetic (PK) food effect study of immediate-release onapristone and its primary metabolite (M1) in healthy female subjects: implications for design of a new formulation
Rezai, Keyvan, Proniuk, Stefan, Zukiwski, Alex, Gilles, Erard, Chassard, Didier, Denot, Caroline, Ramos, Haydee L., Bexon, Alice S., Lokiec, François
Published in Cancer research (Chicago, Ill.) (01.10.2014)
Published in Cancer research (Chicago, Ill.) (01.10.2014)
Get full text
Journal Article
Abstract 1646: Synthesis of [11C]onapristone for clinical investigation
Madar, Olivier, Fouque, Julien, Proniuk, Stefan, Rezai, Keyvan, Huguet, Samuel, Zukiwski, Alexander, Gilles, Erard M., Bexon, Alice S., Lokiec, François
Published in Cancer research (Chicago, Ill.) (01.10.2014)
Published in Cancer research (Chicago, Ill.) (01.10.2014)
Get full text
Journal Article
Validation of a population pharmacokinetic (PPK) model for onapristone (ONA) in patients (pts) with cancer: Analysis of 2 clinical trials
Rezai, Keyvan, Huguet, Samuel, Bret, Fanny, Cottu, Paul H., Attard, Gerhardt, Italiano, Antoine, Varga, Andrea, Bonneterre, Jacques, Campone, Mario, Jayaram, Anuradha, Bexon, Alice Susannah, Gilles, Erard M., Proniuk, Stefan, Barranco, Charles, Zukiwski, Alexander, Lokiec, Francois Marc
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article
Phase 1-2 study of progesterone receptor (PR) inhibition with extended-release (ER) onapristone (ONA) alone or in combination with abiraterone (AA) in patients (pts) with castration-resistant prostate cancer (CRPC) incorporating plasma DNA analysis to define androgen receptor (AR) status
Jayaram, Anuradha, Nowakowska, Karolina, Mateo, Joaquin, Kumar, Sanjeev, Hernandez, Tatiana, Fulton, Ben, Nava Rodrigues, Daniel, Riisnaes, Ruth, Zukiwski, Alexander, Bexon, Alice Susannah, Proniuk, Stefan, Barranco, Charles, Bianchini, Diletta, Zafeirou, Zafeiris, Perez Lopez, Raquel, Tunariu, Nina, Pacey, Simon, Jones, Robert J., De Bono, Johann S., Attard, Gerhardt
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
Abstract 4523: Population pharmacokinetic (PPK) modeling of onapristone in patients (pts) with progesterone receptor (PR)-expressing cancers
Rezai, Keyvan, Cottu, Paul, Huguet, Samuel, Campone, Mario, Italiano, Antoine, Varga, Andrea, Bonneterre, Jacques, Leary, Alexandra, Sablin, Marie-Paule, Proniuk, Stefan, Bexon, Alice, Gilles, Erard, Bisaha, Joseph, Zukiwski, Alexander, Lokiec, Francois
Published in Cancer research (Chicago, Ill.) (01.08.2015)
Published in Cancer research (Chicago, Ill.) (01.08.2015)
Get full text
Journal Article
Abstract 4512: Onapristone in patients (pts) with progesterone receptor (PR)-expressing cancers: PK results from part 1 of a randomized, parallel-dose phase 1 study
Lokiec, Francois, Italiano, Antoine, Varga, Andrea, Bonneterre, Jacques, Campone, Mario, Leary, Alexandra, Rezai, Keyvan, Sablin, Marie-Paule, Bexon, Alice, Proniuk, Stefan, Gilles, Erard, Bisaha, Joseph, Zukiwski, Alexander, Cottu, Paul
Published in Cancer research (Chicago, Ill.) (01.08.2015)
Published in Cancer research (Chicago, Ill.) (01.08.2015)
Get full text
Journal Article
Phase 1-2 study of progesterone receptor (PR) inhibition with extended-release (ER) onapristone (ONA) in patients (pts) with castration-resistant prostate cancer (CRPC): PK, safety and PR testing results from the dose escalation cohort
Jayaram, Anuradha, Nowakowska, Karolina, Mateo, Joaquin, Nava Rodrigues, Daniel, Riisnaes, Ruth, Zukiwski, Alexander, Proniuk, Stefan, Bexon, Alice Susannah, Bisaha, Joseph, Bianchini, Diletta, Zafeiriou, Zafeiris, Perez Lopez, Raquel, Tunariu, Nina, De Bono, Johann Sebastian, Attard, Gerhardt
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
A phase 1-2 study of the type I progesterone receptor (PR) antagonist onapristone (ONA) in patients (pts) with advanced castration-resistant prostate cancer (CRPC)
Mateo, Joaquin, Nava Rodrigues, Daniel, Perez Lopez, Raquel, Flohr, Penelope, Riisnaes, Ruth, Lokiec, Francois Marc, Zukiwski, Alexander, Proniuk, Stefan, Bexon, Alice Susannah, Paquin, Andre, Bisaha, Joseph, Tunariu, Nina, De Bono, Johann Sebastian, Attard, Gerhardt
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
A single-dose PK study of onapristone including the effect of food on absorption
Rezai, Keyvan, Chassard, Didier, Denot, Caroline, Proniuk, Stefan, Zukiwski, Alexander, Gilles, Erard, Ramos, Haydeé L., Patat, Alain, Bexon, Alice, Lokiec, François
Published in Cancer chemotherapy and pharmacology (01.07.2015)
Published in Cancer chemotherapy and pharmacology (01.07.2015)
Get full text
Journal Article
A first-in-human phase I trial of AR-12, a PDK-1 inhibitor, in patients with advanced solid tumors
Mateo, Joaquin, De Bono, Johann Sebastian, Ramanathan, Ramesh K., Lustberg, Maryam B., Zivi, Andrea, Basset, Dawn, Ng, Matthew, Young, Anna-Mary, Garrett, Michelle, Decordova, Shaun, Raynaud, Florence I., Yap, Timothy Anthony, Zukiwski, Alexander A., Proniuk, Stefan, Shapiro, Charles L.
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article